FDA Device Intelligence
HomeCLINICAL DIAGNOSTIC SOLUTIONS, INC. › AMYLASE (CNPG3) Reagent Set

AMYLASE (CNPG3) Reagent Set

CLINICAL DIAGNOSTIC SOLUTIONS, INC. · Model 4 x 120 mL · UDI-DI 00812137011879

CIJ
10
510(k) clearances
1
Adverse events
1
Recalls
6
Facilities

Description

For the quantitative kinetic determination of amylase activity in human serum using a manual or automated procedure. The determination of amylase activity in serum is most commonly performed for the diagnosis and treatment of diseases of the pancreas.

Recalls

DateFirmReason
2020-07-10RANDOX LABORATORIES, LTD.Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.